Clinical trials: Thalassemia; Mixed

Anemia, Sickle Cell, Complex and Transfusion-dependent Hemoglobinopathies

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

• Withdrawn
• Age: Up to 45 years
• Phase 1/2
• Injection or infusion

The goal of this research study is to establish chimerism and avoid graft-versus-host disease in patients with hemoglobinopathies.

Conditions

Anemia, Sickle Cell, Complex and Transfusion-dependent Hemoglobinopathies, Thalassemia, Diamond-Blackfan Anemia

Trial name

NCT01419704

Testing

Enriched Hematopoetic Stem Cell Infusion

Where

3 sites in United States

Sponsor

Talaris Therapeutics Inc.